On the PharmaIntelligence platform, Rutgers subscribes to three daily publications that provide full-text articles related to regulations, corporate news, mergers and acquisitions, product development, patent information, and statistical data (i.e. sales and market share) in the pharmaceutical industry and healthcare sector. Rutgers subscribes to the following publications:
- The Pink Sheet (drug developments and regulatory changes across the industry; includes The Tan Sheet and The Gold Sheet)
- HBW Insight (Over the counter drugs, supplements, and cosmetics sectors; formerly known as The Rose Sheet)
- MedTech Insight (medical device, diagnostic and biotech sectors; includes The Gray Sheet)
Rutgers does not subscribe to any other publications or products on this platform.
Varies by publication.